Your browser is no longer supported. Please, upgrade your browser.
Settings
CLMT Calumet Specialty Products Partners, L.P. daily Stock Chart
CLMT [NASD]
Calumet Specialty Products Partners, L.P.
Index- P/E- EPS (ttm)-4.18 Insider Own1.90% Shs Outstand77.80M Perf Week4.29%
Market Cap283.97M Forward P/E- EPS next Y-1.30 Insider Trans12.64% Shs Float60.38M Perf Month-1.35%
Income-322.00M PEG- EPS next Q-0.62 Inst Own13.30% Short Float1.16% Perf Quarter-12.05%
Sales3.60B P/S0.08 EPS this Y-104.10% Inst Trans-5.09% Short Ratio2.29 Perf Half Y-1.35%
Book/sh2.61 P/B1.40 EPS next Y24.00% ROA-11.20% Target Price4.96 Perf Year-26.56%
Cash/sh0.05 P/C67.61 EPS next 5Y10.00% ROE-103.00% 52W Range2.79 - 6.42 Perf YTD-8.75%
Dividend- P/FCF- EPS past 5Y-44.30% ROI-7.50% 52W High-43.93% Beta1.46
Dividend %- Quick Ratio0.50 Sales past 5Y2.80% Gross Margin11.30% 52W Low29.03% ATR0.13
Employees2000 Current Ratio1.30 Sales Q/Q5.40% Oper. Margin-4.80% RSI (14)42.59 Volatility3.84% 3.47%
OptionableYes Debt/Eq9.84 EPS Q/Q35.70% Profit Margin-8.90% Rel Volume0.73 Prev Close3.65
ShortableYes LT Debt/Eq9.83 EarningsMay 04 BMO Payout- Avg Volume305.37K Price3.60
Recom3.30 SMA20-2.08% SMA50-4.23% SMA200-16.82% Volume85,767 Change-1.37%
Mar-24-17Downgrade Credit Suisse Neutral → Underperform
Nov-04-16Upgrade Credit Suisse Underperform → Neutral
Sep-09-16Initiated FBR Capital Mkt Perform $6
May-06-16Reiterated RBC Capital Mkts Sector Perform $7 → $5
May-05-16Upgrade DA Davidson Underperform → Neutral $5
May-05-16Reiterated Cowen Market Perform $10 → $5
Apr-22-16Downgrade Ladenburg Thalmann Buy → Neutral
Apr-19-16Downgrade DA Davidson Buy → Underperform $5
Apr-18-16Reiterated Scotia Howard Weil Sector Underperform $19 → $5
Apr-18-16Reiterated Cowen Market Perform $23 → $10
Apr-18-16Downgrade Wells Fargo Outperform → Market Perform
Apr-18-16Downgrade Raymond James Mkt Perform → Underperform
Apr-11-16Downgrade Credit Suisse Outperform → Underperform
Feb-19-16Downgrade Credit Suisse Outperform → Neutral
Feb-18-16Reiterated RBC Capital Mkts Outperform $27 → $22
Feb-18-16Reiterated Cowen Buy $32 → $23
Nov-23-15Initiated Goldman Neutral
Nov-16-15Resumed RBC Capital Mkts Outperform $32
Nov-16-15Initiated DA Davidson Buy $34
Mar-04-15Reiterated MLV & Co Buy $30.50 → $32
Apr-28-17 11:15AM  CVR Refinings 1Q17 Results Driven by Throughput Volumes, Spreads Market Realist
Apr-21-17 11:31AM  7 Things You Didn't Know About Calumet Specialty Products Partners LP Motley Fool
09:00AM  Calumet Specialty Products Partners, L.P. To Release First Quarter 2017 Results on May 4th PR Newswire
Apr-11-17 10:36AM  Where Calumet Specialty Products May Be Headed Market Realist
09:06AM  Calumets Institutional Ownership: Key Indications Market Realist
07:37AM  Calumets Leverage Moves in Right DirectionBut Remains High Market Realist
Apr-10-17 05:35PM  Will Calumet Generate Positive Distributable Cash Flow in 2017? Market Realist
04:05PM  Inside Calumet Segmental Performances Market Realist
02:08PM  Calumet Stock: Any Sign of Recovery? Market Realist
Apr-04-17 11:05AM  Integrated Energy and Refiners: Options for Option Traders Market Realist
11:05AM  Integrated Energy and Refiners: Options for Option Traders
11:05AM  Integrated Energy and Refiners: Inside the Returns and Volatilities Market Realist
11:05AM  Integrated Energy and Refiners: Inside the Returns and Volatilities
Mar-31-17 04:26PM  CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation F
04:15PM  Calumet Specialty Products Partners, L.P. Announces Change of Board of Directors' Composition PR Newswire
12:36PM  Integrated Energy and Refiner Stocks Returns and Volatilities Market Realist
12:36PM  Integrated Energy and Refiner Stocks Returns and Volatilities
10:53AM  Integrated Energy and Refiners: Who Tops in Implied Volatility? Market Realist
10:53AM  Integrated Energy and Refiners: Who Tops in Implied Volatility?
Mar-17-17 11:10AM  Integrated Energy and Refiner Stocks Implied Volatilities Market Realist
11:10AM  Integrated Energy and Refiner Stocks Implied Volatilities
Mar-10-17 04:05PM  Implied Volatilities of Integrated Energy and Refiners Market Realist
04:05PM  Implied Volatilities of Integrated Energy and Refiners
02:14PM  Integrated Energy and Refiners: Who Leads in Implied Volatility? Market Realist
02:14PM  Integrated Energy and Refiners: Who Leads in Implied Volatility?
01:04PM  CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. Financials
Mar-09-17 12:16PM  Calumet Specialty Products Partners LP :CLMT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Capital Cube
12:16PM  Calumet Specialty Products Partners LP :CLMT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017
Mar-08-17 01:15PM  Calumet Specialty Products Partners' Management Sounds Very Hopeful, Here's Why Motley Fool
01:15PM  Calumet Specialty Products Partners' Management Sounds Very Hopeful, Here's Why at Motley Fool
Mar-06-17 05:27PM  CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. Files SEC form 10-K, Annual Report
Mar-03-17 12:05PM  Integrated Energy and Refiner Stock Returns Impact Volatility
Feb-27-17 09:40AM  Signs of Hope Are Starting to Show up in Calumet Specialty Products Partners Earnings at Motley Fool
Feb-24-17 05:20PM  Edited Transcript of CLMT earnings conference call or presentation 24-Feb-17 2:00pm GMT -5.00%
12:05PM  How Integrated Energy and Refiners Returns Impacted Volatility
07:07AM  Q4 2016 Calumet Specialty Products Partners LP Earnings Release - Before Market Open
06:28AM  CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. Files SEC form 8-K, Results of Operations and Financial Condition, Financia
06:00AM  Calumet Specialty Products Partners, L.P. Reports Fourth Quarter and Full Year 2016 Results PR Newswire
Feb-23-17 05:06PM  Nearly 75% of Analysts Rate Alon USA Partners a Hold +5.26%
08:44AM  Should You Buy Calumet Specialty Products (CLMT) Ahead of Earnings?
Feb-17-17 12:27PM  Earnings Rally: CVR Energy Is the Top High Volatility Gainer
12:27PM  Why Options Traders Are Watching Alon USA Energy
Feb-14-17 08:58AM  3 Energy Stocks We Love to Hate at Motley Fool
Feb-13-17 07:37AM  70% of Analysts Rate CVR Refining as a Hold ahead of 4Q16 Results
Feb-10-17 04:34PM  What to Expect from CVR Refinings 4Q16 Results
09:18AM  Implied Volatility and Returns: Why Did BP Underperform?
09:18AM  CVR Energys Volatility Is Rising before Its Earnings
Feb-03-17 09:00AM  Calumet Specialty Products Partners, L.P. To Release Fourth Quarter and Full Year 2016 Results on February 24 PR Newswire
07:52AM  Analyzing Integrated Energy Stocks with High Implied Volatility
07:52AM  Why Is CVR Refinings Volatility Rising?
Jan-27-17 12:05PM  Analyzing Returns of Integrated Energy and Refining Companies
Jan-25-17 01:43PM  3 Stocks to Avoid in Energy Despite the Oil Price Rally at Motley Fool
Jan-20-17 11:15AM  Why Did CVR Energys Implied Volatility Rise?
11:15AM  Returns of Integrated Energy and Refining Companies
Jan-19-17 08:42AM  Calumet Specialty Products Partners LP breached its 50 day moving average in a Bearish Manner : CLMT-US : January 19, 2017
Jan-13-17 12:35PM  Whats behind High Implied Volatilities?
10:52AM  Integrated Energy and Refiner Stocks with High Implied Volatility
Jan-08-17 06:27AM  The Worst Energy Stocks of 2016 at Motley Fool
Jan-06-17 02:35PM  Which MLP Stocks Were the Biggest Losers of 2016?
06:03AM  CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. Files SEC form 8-K, Change in Directors or Principal Officers, Financial St
Jan-05-17 08:38AM  Calumet Specialty Products Partners LP breached its 50 day moving average in a Bullish Manner : CLMT-US : January 5, 2017
07:30AM  Calumet Specialty Products Partners, L.P. Names D. West Griffin As EVP & Chief Financial Officer PR Newswire
Dec-30-16 08:37AM  Integrated Energy and Refiner Stocks with High Implied Volatility
Dec-23-16 07:10AM  Calumet Specialty Products Partners LP breached its 50 day moving average in a Bullish Manner : CLMT-US : December 23, 2016
Dec-11-16 07:17AM  Do Hedge Funds Love Liquidity Services, Inc. (LQDT)? at Insider Monkey
Dec-08-16 12:48PM  The Worst High-Yield Dividend Stocks of 2016 at Motley Fool
Dec-05-16 02:39PM  Here's Why Shares of Calumet Specialty Products Partners Surged Ahead in November at Motley Fool +5.68%
01:58PM  Calumet Specialty Products Partners LP Value Analysis (NASDAQ:CLMT) : December 5, 2016
Dec-02-16 04:15PM  Calumet Specialty Products Partners, L.P. To Attend Upcoming Investor Conference PR Newswire
07:05AM  Calumet Specialty Products Partners LP breached its 50 day moving average in a Bullish Manner : CLMT-US : December 2, 2016
Nov-30-16 11:04AM  Refining MLPs Have Reduced Capital Spending +5.26%
10:04AM  CLMTs Leverage Worsens: A Key Concern for Investors
08:04AM  How CLMTs Distributions Differ from CVRRs and ALDWs
Nov-29-16 11:04AM  CVRR, CLMT, ALDW: Who Has More Cash Available for Distribution?
08:05AM  CLMT Reduces Capital Spending Significantly in 2016
Nov-28-16 02:04PM  ALDW, CVRR, CLMT: What Do the Refining Margins Indicate? -7.06%
01:04PM  Piper Jaffray Upgrades CVR Refining to Hold
10:59AM  Refining MLPs Surge after Trumps Victory: Which One Looks Best?
Nov-23-16 01:29PM  3 Dividend Stocks I'd Never Buy at Motley Fool
Nov-22-16 11:48AM  Carl Icahn: If Oil Refiners Crash, So Will The Economy
Nov-12-16 12:10PM  3 Energy Stocks We Love to Hate at Motley Fool
Nov-09-16 04:37PM  CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. Files SEC form 10-Q, Quarterly Report +7.35%
09:22AM  Why Shares of Calumet Specialty Products Partners Sank 19.9% in October at Motley Fool
Nov-07-16 05:04PM  What Catalysts Could Fuel Calumets Near-Term Growth?
02:58PM  What Affected Calumet Specialty Products Partners 3Q16 Results?
Nov-04-16 11:36AM  Calumet Specialty Products Partners LP :CLMT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016
08:49AM  Integrated Energy and Refiner Stocks with High Implied Volatility
08:12AM  Calumet Specialty Products upgraded by Credit Suisse
Nov-03-16 06:54PM  Edited Transcript of CLMT earnings conference call or presentation 3-Nov-16 5:00pm GMT -11.27%
11:11AM  Calumet Specialty Products Partners' Earnings Show Modest Gains, Long Path to Profitability at Motley Fool
08:34AM  CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. Files SEC form 8-K, Results of Operations and Financial Condition, Financia
08:00AM  Calumet Specialty Products Partners, L.P. Reports Third Quarter 2016 Results PR Newswire
07:07AM  Q3 2016 Calumet Specialty Products Partners LP Earnings Release - Before Market Open
Oct-28-16 08:05AM  Alon USA Partners after 3Q16: Is a Recovery in Sight?
Oct-27-16 08:04AM  Most Analysts Rate Calumet a Hold ahead of 3Q16 Results
Oct-26-16 02:04PM  Can Calumet Stock Recover after 3Q16 Results?
12:04PM  Can Calumets Fuel Products Segment Recover in 3Q16?
10:29AM  Calumet Is Expected to Report Marginally Higher 3Q16 Earnings
Oct-17-16 08:05AM  Refining Stocks Implied Volatility Is Rising, But Why?
Oct-13-16 04:15PM  Calumet Specialty Products Partners, L.P. Schedules Third Quarter 2016 Results Conference Call PR Newswire
Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America. It operates in three segments: Specialty Products, Fuel Products, and Oilfield Services. The Specialty Products segment offers various lubricating oils, white mineral oils, petrolatums, solvents, waxes, synthetic lubricants, and other products which are used primarily as raw material components for basic automotive, industrial, and consumer goods. The Fuel Products segment provides fuel and fuel-related products, including gasoline, diesel, jet fuel, asphalt, and heavy fuel oils, as well as resells purchased crude oil to third party customers. The Oilfield Services segment manufactures and markets drilling fluids, completion fluids, and solids control services to the oil and gas exploration industry. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mawer Stephen PDirectorMar 07Buy3.903,60014,02229,037Mar 08 08:08 AM
Schumacher Amy MDirectorMar 01Option Exercise0.009,447019,945Mar 03 05:52 PM
Sajkowski Daniel JDirectorMar 01Option Exercise0.009,447014,545Mar 03 05:50 PM
Mawer Stephen PDirectorMar 01Option Exercise0.007,937025,437Mar 03 05:49 PM
Funk Robert EDirectorMar 01Option Exercise0.0013,805064,141Mar 03 05:41 PM
Morris George C IIIDirectorMar 01Option Exercise0.0010,359093,892Mar 03 05:42 PM
Fehsenfeld Fred M JrChairman of the BoardMar 01Option Exercise0.0013,7100452,408Mar 03 05:38 PM
Carter James SDirectorMar 01Option Exercise0.0013,9610107,402Mar 03 05:37 PM
William A AndersonEVP - SalesMar 01Option Exercise0.005,400065,400Mar 03 05:27 PM
Go TimothyChief Executive OfficerMar 01Option Exercise0.007,5960123,108Mar 03 05:24 PM
Murray Richard Patrick IIEVP and CFOMar 01Option Exercise0.009,856098,691Mar 03 05:21 PM
Grube Ferdinand WilliamExecutive Vice Chairman of BODMar 01Option Exercise0.008,1000189,828Mar 03 05:20 PM
Fleming Bruce AEVP - Strategy & GrowthMar 01Option Exercise0.0035,7600178,799Mar 03 05:17 PM
Go TimothyChief Executive OfficerFeb 28Buy3.9420,00078,800111,682Mar 02 07:19 AM
Go TimothyChief Executive OfficerNov 25Buy4.257693,26891,682Nov 28 05:37 PM
Go TimothyChief Executive OfficerNov 18Buy4.655,00023,25090,913Nov 21 05:05 PM
Go TimothyChief Executive OfficerNov 17Buy4.855,00024,24585,913Nov 21 05:05 PM
Go TimothyChief Executive OfficerNov 16Buy4.808574,11480,913Nov 17 07:05 PM
Fleming Bruce AEVP - Strategy & GrowthNov 15Buy4.3340173143,039Nov 16 08:35 AM
Go TimothyChief Executive OfficerNov 15Buy4.4510044580,056Nov 17 07:05 PM
William A AndersonEVP - SalesNov 14Buy4.1020,10882,44360,000Nov 15 04:27 PM
Go TimothyChief Executive OfficerNov 11Buy4.205,00020,99079,956Nov 14 08:42 AM
Go TimothyChief Executive OfficerNov 10Buy4.305,00021,49374,956Nov 14 08:42 AM
Mawer Stephen PDirectorNov 09Buy3.654,00014,58017,500Nov 09 05:32 PM
Fleming Bruce AEVP - Strategy & GrowthNov 08Buy3.3957,999196,617142,999Nov 10 05:39 PM
Go TimothyChief Executive OfficerNov 08Buy3.376,60422,23869,956Nov 14 08:42 AM
William A AndersonEVP - SalesNov 07Buy3.403,67012,4783,550Nov 09 06:38 PM
William A AndersonEVP - SalesNov 07Buy3.4014,50049,30039,892Nov 09 06:38 PM
Fehsenfeld Fred M JrChairman of the BoardSep 23Option Exercise0.00750438,698Sep 27 05:18 PM
Funk Robert EDirectorSep 23Option Exercise0.0078050,336Sep 27 05:17 PM
Fleming Bruce AEVP - Strategy & GrowthAug 24Buy5.5015,00082,50085,000Aug 25 04:09 PM
Mawer Stephen PDirectorAug 19Buy5.612,50014,02513,500Aug 22 07:49 AM
Carter James SDirectorMay 26Buy3.7013,60050,32093,441Mar 01 06:20 PM
Go TimothyChief Executive OfficerMay 20Option Exercise0.0053,897081,504May 25 06:06 PM
Murray Richard Patrick IIEVP and CFOMay 20Option Exercise0.0055,0100106,244May 25 06:00 PM
Grube Ferdinand WilliamExecutive Vice Chairman of BODMay 20Option Exercise0.0081,8050207,620May 25 05:57 PM
Mawer Stephen PDirectorMay 18Buy3.6811,00040,43911,000May 19 05:26 PM
Go TimothyChief Executive OfficerMay 12Buy3.8225,00095,50027,607May 16 08:10 AM
Murray Richard Patrick IIEVP and CFOMay 09Buy4.015,00020,05051,234May 11 07:58 AM
William A AndersonEVP - SalesMay 09Buy4.0710,00040,70025,392May 11 07:54 AM
NLNK NewLink Genetics Corporation daily Stock Chart
NLNK [NASD]
NewLink Genetics Corporation
Index- P/E- EPS (ttm)-2.94 Insider Own1.50% Shs Outstand30.43M Perf Week0.60%
Market Cap559.00M Forward P/E- EPS next Y-2.68 Insider Trans-0.86% Shs Float21.70M Perf Month-11.04%
Income-85.20M PEG- EPS next Q-0.82 Inst Own49.00% Short Float10.76% Perf Quarter50.57%
Sales35.80M P/S15.61 EPS this Y-108.00% Inst Trans-0.20% Short Ratio3.69 Perf Half Y34.78%
Book/sh4.44 P/B4.14 EPS next Y4.30% ROA-46.00% Target Price26.20 Perf Year12.98%
Cash/sh4.32 P/C4.25 EPS next 5Y- ROE-57.40% 52W Range9.23 - 25.17 Perf YTD78.70%
Dividend- P/FCF- EPS past 5Y0.30% ROI-65.70% 52W High-25.63% Beta1.21
Dividend %- Quick Ratio4.40 Sales past 5Y80.40% Gross Margin- 52W Low102.81% ATR1.54
Employees122 Current Ratio4.40 Sales Q/Q64.90% Oper. Margin- RSI (14)52.72 Volatility6.57% 9.49%
OptionableYes Debt/Eq0.00 EPS Q/Q38.20% Profit Margin- Rel Volume0.54 Prev Close18.37
ShortableYes LT Debt/Eq0.00 EarningsMay 04 BMO Payout- Avg Volume632.95K Price18.72
Recom1.80 SMA201.67% SMA50-0.15% SMA20037.69% Volume130,171 Change1.90%
Mar-30-17Upgrade SunTrust Hold → Buy
May-11-16Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
May-10-16Reiterated Stifel Buy $63 → $23
May-10-16Reiterated Mizuho Buy $52 → $20
Mar-23-16Initiated Robert W. Baird Outperform $27
Mar-01-16Reiterated Mizuho Buy $62 → $52
Jul-15-15Reiterated Mizuho Buy $50 → $62
Jul-15-15Reiterated Cantor Fitzgerald Buy $44 → $62
May-06-15Reiterated Stifel Buy $59 → $63
Nov-07-14Reiterated Stifel Buy $51 → $55
Sep-12-14Initiated Mizuho Buy $50
Mar-31-14Reiterated MLV & Co Buy $29 → $45
Mar-03-14Downgrade Robert W. Baird Outperform → Neutral
Jan-22-14Reiterated Stifel Buy $31 → $53
Dec-13-13Reiterated Stifel Buy $28 → $31
Sep-30-13Reiterated MLV & Co Buy $24 → $29
Aug-08-13Reiterated Stifel Buy $25 → $28
Aug-08-13Reiterated MLV & Co Buy $18.50 → $24
Jun-04-13Reiterated MLV & Co Buy $18.50 → $24
May-29-13Reiterated Cantor Fitzgerald Buy $18 → $25
Apr-25-17 12:34AM  Vaunted Ebola Vaccine Faces Questions The Wall Street Journal
Apr-24-17 06:23PM  Vaunted Ebola Vaccine Faces Questions The Wall Street Journal
Apr-21-17 03:41PM  NewLink Genetics Corp. Value Analysis (NASDAQ:NLNK) : April 21, 2017 Capital Cube
12:02PM  Should Gilead Sciences Acquire NewLink Genetics? Motley Fool
07:00AM  NewLink Genetics Announces Presentation of Two Abstracts at ASCO GlobeNewswire
Apr-20-17 08:20AM  NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : April 20, 2017 Capital Cube
Apr-13-17 12:01PM  Morgan Stanley Ups Incyte Target to $150 Barrons.com
10:41AM  The IDO-Inhibitor Race Is On to Improve Cancer Treatment Motley Fool
08:00AM  NewLink Genetics to Host Its First Quarter 2017 Financial Results Conference Call on May 4, 2017 GlobeNewswire
Apr-07-17 05:08PM  ETFs with exposure to NewLink Genetics Corp. : April 7, 2017 Capital Cube -7.70%
10:17AM  NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : April 7, 2017 Capital Cube
Apr-05-17 04:56PM  Why NewLink Genetics, Harmonic, and Innophos Holdings Slumped Today Motley Fool -14.00%
Apr-04-17 05:07PM  Why NewLink Genetics Shares Fell 10.3% Today Motley Fool -9.96%
04:02PM  NEWLINK GENETICS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In NewLink Genetics Corporation (NLNK) To Contact The Firm Business Wire
09:48AM  NewLink Genetics Corp. stock drops 28% on mid-stage results for melanoma drug MarketWatch
08:30AM  Interim Phase 2 Data Demonstrate Robust Response Rate with Indoximod in Combination with Keytruda® (pembrolizumab) for Patients with Advanced Melanoma at AACR Plenary GlobeNewswire
Mar-31-17 09:30AM  TrovaGene and NewLink Genetics Find Investors Optimistic About Products Accesswire
Mar-30-17 04:07PM  NewLink Genetics' shares surge after upgrade, seen as takeover target CNBC +5.62%
10:33AM  5 Top Performing Stocks of the Best ETF of Q1 Zacks
07:08AM  NewLink Genetics upgraded by SunTrust
Mar-20-17 08:34AM  NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Di
Mar-17-17 08:15AM  Blog Coverage PTC Therapeutics Acquires Rights for Duchenne Muscular Dystrophy Drug from Marathon for $140 Million Upfront Accesswire
Mar-10-17 01:04PM  NEWLINK GENETICS CORP Financials
Mar-07-17 01:23PM  NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Capital Cube -5.21%
Mar-06-17 02:16PM  NEWLINK GENETICS CORP Files SEC form 10-K, Annual Report
07:04AM  Four Companies Breaking Out Right Now With Record Growth
Mar-01-17 05:30PM  NEWLINK GENETICS CORP Files SEC form 8-K, Other Events +6.81%
05:05PM  NewLink Genetics Announces Presentation of Two Abstracts at AACR GlobeNewswire
Feb-28-17 08:45AM  NewLink reports 4Q loss
08:35AM  NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  NewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 NewLink Genetics Corp Earnings Release - Before Market Open
Feb-21-17 10:02AM  NewLink Genetics (NLNK): Moving Average Crossover Alert
Feb-20-17 07:00AM  NewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017 GlobeNewswire
Feb-13-17 05:14PM  [$$] Cevec Pharma, NewLink Genetics Target Zika Through Licensing Deal at The Wall Street Journal
07:00AM  NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th GlobeNewswire
Feb-10-17 03:25AM  Will NewLink Genetics (NLNK) Continue to Surge Higher?
Jan-18-17 03:40PM  Lifshitz & Miller Law Firm Announces Investigation of DaVita Inc., First NBC Bank Holdings Company, Fresenius Medical Care AG & Co. KGAA, Inotek Pharmaceuticals Corporation, Natural Health Trends Corp., NeoPhotonics Corporation, NewLink Gen PR Newswire
Jan-11-17 11:19AM  NewLink Genetics Corp. Value Analysis (NASDAQ:NLNK) : January 11, 2017 -5.80%
Jan-10-17 07:18AM  NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : January 10, 2017
Jan-09-17 04:45PM  Newman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation Business Wire +18.30%
Jan-05-17 05:17PM  NEWLINK GENETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
Dec-27-16 01:31PM  ETFs with exposure to NewLink Genetics Corp. : December 27, 2016
08:30AM  NewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session
Dec-23-16 11:42AM  Shark Bites: We Knew Today Would Be Slow, but Come On +9.79%
Dec-20-16 01:49PM  Do Hedge Funds Love Western Asset Mortgage Capital Corp (WMC)? at Insider Monkey
Dec-16-16 02:06PM  ETFs with exposure to NewLink Genetics Corp. : December 16, 2016
Dec-15-16 06:42PM  How Mercantile Bank Corp. (MBWM) Compares To Its Peers at Insider Monkey
Dec-13-16 04:31PM  NEWLINK GENETICS CORP Files SEC form 8-K/A, Termination of a Material Definitive Agreement
Dec-10-16 03:08PM  Hedge Funds Are Dumping Monarch Casino & Resort, Inc. (MCRI) at Insider Monkey
Dec-09-16 03:04PM  Inovio Pharmaceuticals, Inc.'s Biggest Win in 2016 at Motley Fool
Nov-29-16 04:19PM  NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-22-16 07:32AM  NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : November 22, 2016
Nov-21-16 12:41PM  Edited Transcript of NLNK earnings conference call or presentation 1-Nov-16 12:30pm GMT
Nov-15-16 06:55AM  Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive
Nov-09-16 07:00AM  NewLink Genetics to Participate in Three Investor Conferences in November GlobeNewswire +10.86%
Nov-08-16 04:19PM  NEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report
Nov-03-16 12:18PM  ETFs with exposure to NewLink Genetics Corp. : November 3, 2016
Nov-02-16 10:45AM  NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016 -7.89%
Nov-01-16 09:10AM  NewLink reports 3Q loss
08:17AM  NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 NewLink Genetics Corp Earnings Release - Before Market Open
Oct-31-16 08:33AM  NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : October 31, 2016
Oct-25-16 05:00PM  NEWLINK GENETICS CORP Files SEC form 8-K, Other Events
04:05PM  NewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor Day GlobeNewswire
Oct-24-16 07:00AM  NewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1, 2016 GlobeNewswire
Oct-20-16 07:00AM  NewLink Genetics to Webcast 2016 Analyst and Investor Day on October 25, 2016 GlobeNewswire
Oct-04-16 05:18PM  NEWLINK GENETICS CORP Files SEC form 8-K, Other Events
04:10PM  NewLink Genetics Awarded $25 Million Contract from BARDA for Investigational Ebola Zaire Vaccine (V920) GlobeNewswire
Sep-30-16 08:02AM  4 momentum stocks to watch at MarketWatch
Sep-29-16 09:45AM  ETFs with exposure to NewLink Genetics Corp. : September 29, 2016
Sep-26-16 08:35AM  Strength Seen in NewLink Genetics (NLNK): Stock Jumps 5%
Sep-19-16 11:26AM  NewLink Genetics Corp. Value Analysis (NASDAQ:NLNK) : September 19, 2016
Sep-16-16 08:16AM  NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : September 16, 2016
Sep-09-16 11:10AM  ETFs with exposure to NewLink Genetics Corp. : September 9, 2016
Sep-01-16 07:00AM  NewLink Genetics to Participate in Baird Healthcare Conference GlobeNewswire
Aug-22-16 11:46AM  ETFs with exposure to NewLink Genetics Corp. : August 22, 2016
Aug-08-16 02:28PM  ETFs with exposure to NewLink Genetics Corp. : August 8, 2016
Aug-05-16 02:15PM  NEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report
11:21AM  NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Jul-29-16 08:24AM  NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition
08:08AM  NewLink reports 2Q loss
08:00AM  NewLink Genetics Reports Second Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q2 2016 NewLink Genetics Corp Earnings Release - Before Market Open
Jul-27-16 08:54AM  Why Earnings Season Could Be Great for NewLink Genetics (NLNK)
Jul-25-16 08:05AM  NewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920) GlobeNewswire
Jul-22-16 08:23AM  NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : July 22, 2016
Jul-20-16 07:00AM  NewLink Genetics to Host Its Second Quarter 2016 Financial Results Conference Call on July 29, 2016 GlobeNewswire +7.06%
Jul-18-16 04:04PM  NewLink Genetics Corp. Value Analysis (NASDAQ:NLNK) : July 18, 2016
Jul-11-16 12:32PM  DEADLINE TODAY: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm Accesswire
08:58AM  Coverage Initiated on Select Biotech Equities
08:18AM  NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : NLNK-US : July 11, 2016
Jul-08-16 11:37PM  72-Hour Deadline Alert: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm Accesswire
10:07PM  NEWLINK 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against NewLink Genetics Corporation - NLNK GlobeNewswire
05:26PM  3-Day Deadline Alert: Lundin Law PC Announces Securities Class Action Lawsuit against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm Accesswire
02:20PM  July 11 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against NewLink Genetics Corporation Business Wire
01:38PM  DEADLINE ALERT - NewLink Genetics Corporation - Brower Piven Reminds Investors Of Upcoming Deadline And Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact The Firm - NLNK GlobeNewswire
10:54AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of NewLink Genetics Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 NLNK GlobeNewswire
NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products for the treatment of cancer. Its portfolio includes biologic product candidates based on its HyperAcute cellular immunotherapy technology, which is designed to stimulate the human immune system to attack cancer cells; and small-molecule product candidates that are focused on breaking the immune system's tolerance to cancer by inhibiting the indoleamine-2, 3-dioxygenase pathway and the tryptophan-2, 3-dioxygenase pathway. The company is developing IDO pathway inhibitors comprising indoximod that is in multiple Phase I and Phase II clinical trials for patients with melanoma, pancreatic cancer, malignant brain tumors, metastatic breast cancer, acute myeloid leukemia, prostate cancer, and non-small cell lung cancer (NSCLC); and GDC-0919 and atezolizumab (MPDL3280A) that is in Phase Ib clinical trials for patients with locally advanced or metastatic solid tumors. Its clinical development products include NLG2101 for metastatic breast cancer; NLG2102 for refractory malignant brain tumors; NLG2103 for advanced melanoma; NLG2104 for metastatic pancreatic cancer; NLG2105 for pediatric patients with refractory malignant brain tumors; and NLG2106 for acute myelogenous leukemia. The company's HyperAcute cellular immunotherapy product candidates under clinical development include tergenpumatucel-L, is being investigated in Phase Ib/II clinical trial for patients with advanced NSCLC; and dorgenmeltucel-L, is being investigated in a Phase II clinical trial for patients with advanced melanoma. Its infectious disease program includes replication-competent recombinant vesicular stomatitis virus, a vaccine technology to treat Ebola and Marburg viruses. The company has license and collaboration agreements with Genentech, Inc. and Merck, Sharpe and Dohme Corp. NewLink Genetics Corporation was founded in 1999 and is headquartered in Ames, Iowa.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Langren Carl W.Principal Accounting OfficerDec 14Sale10.853,94342,78210,691Dec 16 05:53 PM
Talarico Ernest IIIDirectorJun 06Buy12.324,06550,08132,223Jun 08 04:20 PM
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-14.47 Insider Own0.20% Shs Outstand224.66M Perf Week7.63%
Market Cap2.53B Forward P/E3.22 EPS next Y3.50 Insider Trans-3.65% Shs Float221.57M Perf Month5.03%
Income-3223.80M PEG- EPS next Q1.10 Inst Own89.50% Short Float10.83% Perf Quarter-5.92%
Sales4.01B P/S0.63 EPS this Y-850.90% Inst Trans-10.35% Short Ratio2.72 Perf Half Y-47.49%
Book/sh12.12 P/B0.93 EPS next Y-2.69% ROA-19.50% Target Price16.78 Perf Year-60.94%
Cash/sh2.30 P/C4.90 EPS next 5Y-2.90% ROE-63.90% 52W Range9.70 - 29.48 Perf YTD-31.51%
Dividend- P/FCF7.15 EPS past 5Y-61.60% ROI-25.30% 52W High-61.52% Beta0.60
Dividend %- Quick Ratio0.80 Sales past 5Y9.70% Gross Margin34.30% 52W Low16.96% ATR0.53
Employees4894 Current Ratio1.00 Sales Q/Q15.60% Oper. Margin-86.60% RSI (14)53.31 Volatility4.61% 5.06%
OptionableYes Debt/Eq3.06 EPS Q/Q-855.30% Profit Margin-83.50% Rel Volume0.91 Prev Close11.28
ShortableYes LT Debt/Eq3.01 EarningsMay 30 BMO Payout- Avg Volume8.83M Price11.35
Recom2.50 SMA203.59% SMA500.17% SMA200-29.71% Volume3,097,680 Change0.58%
Feb-22-17Initiated Canaccord Genuity Hold $14
Jan-31-17Reiterated Mizuho Buy $25 → $15
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-05-17Downgrade Citigroup Buy → Neutral
Dec-07-16Resumed Oppenheimer Perform
Nov-11-16Reiterated Mizuho Buy $29 → $25
Nov-10-16Upgrade Susquehanna Neutral → Positive
Nov-09-16Reiterated RBC Capital Mkts Outperform $26 → $21
Sep-29-16Upgrade Northland Capital Market Perform → Outperform
Aug-12-16Upgrade Mizuho Neutral → Buy $16 → $29
Jun-13-16Upgrade Mizuho Underperform → Neutral $13 → $16
Jun-06-16Initiated Goldman Neutral $20
May-18-16Reiterated Stifel Buy $75 → $25
May-09-16Reiterated Deutsche Bank Buy $61 → $31
May-06-16Reiterated Stifel Buy $90 → $75
May-06-16Reiterated Barclays Equal Weight $37 → $28
May-06-16Downgrade Piper Jaffray Overweight → Neutral
May-06-16Downgrade Mizuho Neutral → Underperform $42 → $13
May-06-16Downgrade Leerink Partners Outperform → Mkt Perform
Apr-21-16Initiated JMP Securities Mkt Outperform
Apr-27-17 06:02PM  These are the only 9 stocks Morningstar is fully bullish on MarketWatch
Apr-26-17 08:28PM  There are only nine five-star U.S. stocks, but dont panic: Morningstar CEO MarketWatch
Apr-25-17 07:30AM  Endo to Announce First-Quarter 2017 Financial Results PR Newswire
Apr-20-17 09:44AM  Biotech Movers: Organovo, Endo, Omeros TheStreet.com
Apr-13-17 05:51PM  Which Drugmakers Will Rock The Sector In Q1? Investor's Business Daily
12:05PM  Endo International plc -- Moody's rates Endo's new secured notes Ba2 Moody's
08:43AM  Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock? Zacks
Apr-12-17 07:19PM  Endo International plc Announces Pricing of Private Offering of Senior Secured Notes PR Newswire
07:19PM  Endo International plc Announces Pricing of Private Offering of Senior Secured Notes CNW Group
Apr-11-17 05:46PM  Endo (ENDP) Reports Preliminary Results for First Quarter Zacks -9.35%
04:41PM  Why AmTrust Financial Services, Endo International, and Hub Group Slumped Today Motley Fool
Apr-10-17 06:23PM  Endo Finance LLC -- Moody's rates Endo's new secured notes Ba2 Moody's
01:27PM  Endo International plc Announces Proposed Private Offering of Senior Secured Notes PR Newswire
01:27PM  Endo International plc Announces Proposed Private Offering of Senior Secured Notes CNW Group
08:14AM  Endo International Plc breached its 50 day moving average in a Bullish Manner : ENDP-US : April 10, 2017 Capital Cube
Apr-07-17 09:25AM  Endo international, AngioDynamics Lead Biotech Movers TheStreet.com
Apr-05-17 07:30AM  Endo International plc Announces Plan to Refinance Existing Credit Agreement PR Newswire
07:30AM  Endo International plc Announces Plan to Refinance Existing Credit Agreement
Apr-04-17 07:00PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's CFR to B2; assigns Ba2 to new secured debt Moody's
07:00PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's downgrades Endo's CFR to B2; assigns Ba2 to new secured debt
Mar-31-17 03:20AM  Why Is Endo (ENDP) Down 10.6% Since the Last Earnings Report? Zacks
03:20AM  Why Is Endo (ENDP) Down 10.6% Since the Last Earnings Report?
Mar-30-17 04:59PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-28-17 05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017? Zacks
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017?
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017? at Investopedia
11:11AM  VIVUS to Regain Commercial Rights for Stendra from Sanofi
Mar-27-17 01:32PM  Shire: Can It Pay Down Debt? Barrons.com +5.32%
01:32PM  Shire: Can It Pay Down Debt? at Barrons.com
Mar-22-17 09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) Motley Fool
09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) at Motley Fool
Mar-20-17 10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Zacks
10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet
Mar-17-17 09:27AM  Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded
Mar-16-17 07:07PM  Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA Zacks
07:07PM  Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA
Mar-15-17 04:04PM  Frontier Communications, Rubicon Project Plunge into Wednesdays 52-Week Low Club 24/7 Wall St.
04:04PM  Frontier Communications, Rubicon Project Plunge into Wednesdays 52-Week Low Club
11:05AM  FDA panel: Endo opioid painkiller's risks outweigh its benefits at bizjournals.com
10:38AM  How Endo's FDA Committee Vote Affects Egalet
12:29AM  [$$] FDA Advisory Panel Says Benefits of Painkiller Opana ER No Longer Outweigh Risks at The Wall Street Journal
Mar-14-17 08:48PM  Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ER PR Newswire
08:28PM  FDA deals blow to Endo over Opana ER Pain Med
05:35PM  Risks of Endo's opioid painkiller outweigh benefits: FDA panel
05:29PM  [$$] FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks at The Wall Street Journal
04:02PM  FDA: Risk of Endo's opioid painkiller outweigh benefits
03:51PM  Risk of Endo's opioid painkiller outweigh benefits: FDA Panel
Mar-09-17 09:05AM  New Strong Sell Stocks for March 9th
Mar-08-17 08:37AM  Why Endo International (ENDP) Could Be Positioned for a Slump
08:29AM  Trumps Tweets Trigger a Sell-Off in the Healthcare Sector
Mar-07-17 01:04PM  ENDO INTERNATIONAL PLC Financials
12:51PM  Supernus, Valeant, Endo Stocks Lose Big After Trump Drug-Pricing Tweet
Mar-06-17 04:22PM  Has Biodelivery Sciences Finally Turned the Corner? at Motley Fool -6.94%
01:36PM  ETFs with exposure to Endo International Plc : March 6, 2017
Mar-03-17 04:30PM  Endo International plc To Delist Ordinary Shares From The Toronto Stock Exchange PR Newswire
Mar-02-17 12:16PM  Endo International Plc :ENDP-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017
Mar-01-17 02:23PM  ENDO INTERNATIONAL PLC Files SEC form 10-K, Annual Report -6.08%
09:47AM  Endo International Plc :ENDP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 1, 2017
Feb-28-17 05:09PM  Edited Transcript of ENDP earnings conference call or presentation 28-Feb-17 1:30pm GMT
12:17PM  Endo (ENDP) Beats on Q4 Earnings, Revenues; Guides Low
10:55AM  Endo profit, sales beat as the drugmaker enters transition phase
10:46AM  Aytu BioScience May Lead the Way in Low T
08:30AM  Endo International PLC Earnings Call scheduled for 8:30 am ET today
08:23AM  Endo (ENDP) Q4 Earnings & Revenues Beat Estimates
07:22AM  Endo reports 4Q loss
07:07AM  Q4 2016 Endo International PLC Earnings Release - Before Market Open
07:00AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
06:44AM  Endo Pharma revenue rises 15.6 pct
06:30AM  Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results PR Newswire
Feb-27-17 10:12AM  On Generic Drugs, Patent 'Death Squads' And The Oscars at Forbes
Feb-24-17 10:43PM  Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility Assurance PR Newswire
08:43AM  Implied Volatility Surging for Endo International (ENDP) Stock Options
Feb-23-17 05:57PM  Incyte, CBOE Holdings, Regency Centers Set to Join S&P 500; Others to Join S&P MidCap 400 PR Newswire
Feb-22-17 05:16PM  Endo (ENDP) to Post Q4 Earnings: Will the Stock Disappoint?
10:23AM  Coverage initiated on Endo Intl by Canaccord Genuity
Feb-16-17 08:04AM  Health Care Sector Led the S&P 500s Rally on February 15
Feb-13-17 07:30AM  Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results PR Newswire
Feb-10-17 12:00PM  Is More Downside Ahead For Teva Pharmaceutical? at Barrons.com
Feb-08-17 01:42PM  Canada's TMX seeks part of Saudi Aramco listing Reuters
Feb-06-17 08:35PM  BioMarin sues to stop generic version of its $90K-a-year drug at bizjournals.com
Feb-01-17 04:18PM  Belbuca return expected to push BDSI to profitability sooner at bizjournals.com
Jan-31-17 05:40PM  Endo's (ENDP) Ephedrine Sulfate Injection Gets FDA Approval
10:44AM  Endo International: We Believe? at Barrons.com
Jan-30-17 05:26PM  Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP PR Newswire
04:19PM  Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised)
Jan-27-17 09:05AM  Endo (ENDP) Restructures its Branded Pharmaceutical Unit
08:58AM  New Strong Sell Stocks for January 27th
Jan-26-17 03:18PM  Weitz Funds Comments on Endo International
06:52AM  Endo to cut 90 jobs as part of drugmaker's restructuring at MarketWatch
06:49AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial Statements an
06:30AM  Endo Announces Actions to Drive Greater Efficiency and Business Alignment PR Newswire
Jan-25-17 10:30AM  Endo Settles FTC 'Pay-for-Delay' Allegations at Investopedia
Jan-24-17 09:50AM  Endo (ENDP) Settles Disputes with Federal Trade Commission
09:26AM  Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo
Jan-23-17 06:28PM  U.S. reaches settlement with Endo on pay-for-delay charges Reuters
04:27PM  Endo Resolves FTC Antitrust Suit, But Allergan Hanging; Stocks Mixed
04:10PM  FTC, Endo propose agreement to resolve pay-for-delay dispute at bizjournals.com
04:04PM  Teva, Gilead Sciences Tumble into Mondays 52-Week Low Club
02:49PM  Allergan Stock is Still Struggling Amid FTC Ruling at Investopedia
02:42PM  FTC settles pay-for-delay lawsuit, files two related complaints Reuters
Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Its U.S. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's U.S. Branded Pharmaceuticals segment offers pain management products, such as Lidoderm, OPAN ER, Percocet, and Voltare Gel. This segment also provides Supprelin LA for central precocious puberty treatment; XIAFLEX for treating Peyronie's and Dupuytren's contracture diseases; Fortesta Gel for hypogonadism treatment; Testim Gel for the treatment of endogenous testosterone; Frova for migraine headaches; Valstar, a sterile solution for intravesical instillation of valrubicin; Vantas for the palliative treatment of prostate cancer; Aveed for the treatment of low testosterone; TESTOPEL, a long-acting implantable pellet; and NASCOBAL, a nasal spray. Its International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, and oncology; generic, branded generic, and over-the-counter products in the areas of dermatology and anti-infectives; and healthcare services, products, and solutions to hospitals, pharmacies, and practitioners, as well as for government healthcare programs. The company also provides injectables for the treatment of pain, anti-infectives, cardiovascular, and other therapeutics areas. It sells its branded pharmaceuticals and generics directly, as well as through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campanelli PaulPresident, CEOMar 16Buy10.722,30024,656207,120Mar 16 05:54 PM
Hutson Nancy JDirectorMar 09Sale10.825,32557,61731,252Mar 10 10:24 AM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,632188,000Nov 16 02:00 PM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,63268,362Nov 16 02:00 PM
SPSC SPS Commerce, Inc. daily Stock Chart
SPSC [NASD]
SPS Commerce, Inc.
Index- P/E170.15 EPS (ttm)0.33 Insider Own0.90% Shs Outstand17.20M Perf Week-6.57%
Market Cap965.78M Forward P/E55.70 EPS next Y1.01 Insider Trans-31.48% Shs Float17.10M Perf Month-2.38%
Income5.70M PEG7.56 EPS next Q0.19 Inst Own- Short Float2.94% Perf Quarter-19.75%
Sales193.30M P/S5.00 EPS this Y21.60% Inst Trans0.65% Short Ratio2.76 Perf Half Y-19.36%
Book/sh14.63 P/B3.84 EPS next Y22.93% ROA2.00% Target Price75.44 Perf Year11.90%
Cash/sh8.08 P/C6.95 EPS next 5Y22.50% ROE2.40% 52W Range48.11 - 74.85 Perf YTD-19.66%
Dividend- P/FCF89.42 EPS past 5Y-21.00% ROI1.80% 52W High-25.64% Beta1.16
Dividend %- Quick Ratio5.80 Sales past 5Y27.20% Gross Margin66.70% 52W Low15.69% ATR1.58
Employees1217 Current Ratio5.80 Sales Q/Q20.80% Oper. Margin3.90% RSI (14)40.51 Volatility3.43% 2.47%
OptionableYes Debt/Eq0.00 EPS Q/Q-17.30% Profit Margin3.00% Rel Volume1.92 Prev Close56.15
ShortableYes LT Debt/Eq0.00 EarningsApr 27 AMC Payout0.00% Avg Volume182.07K Price55.66
Recom2.10 SMA20-4.57% SMA50-1.84% SMA200-14.00% Volume134,166 Change-0.87%
Apr-28-17Reiterated Needham Buy $70 → $64
Feb-08-17Downgrade Pacific Crest Overweight → Sector Weight
Feb-08-17Downgrade Canaccord Genuity Buy → Hold $82 → $65
Dec-06-16Initiated The Benchmark Company Buy $84
Sep-30-16Initiated Pacific Crest Overweight $85
Sep-27-16Initiated First Analysis Sec Overweight $86
Sep-26-16Reiterated Needham Buy $70 → $83
Jul-27-16Reiterated Needham Buy $60 → $70
Jul-24-15Reiterated Stifel Buy $80 → $85
Jul-24-15Reiterated Northland Capital Outperform $82 → $87
Jul-24-15Reiterated Canaccord Genuity Buy $80 → $83
Jul-23-15Reiterated Needham Buy $72 → $86
Jun-28-13Reiterated Stifel Buy $46 → $60
Apr-26-13Reiterated Northland Capital Outperform $43 → $48
Apr-02-13Initiated Maxim Group Buy $50
Oct-26-12Reiterated Needham Buy $37 → $43
Oct-22-12Upgrade Canaccord Genuity Hold → Buy $45
Aug-08-12Reiterated Needham Buy $34 → $37
Jun-21-12Initiated Northland Securities Outperform $34
Feb-09-12Reiterated Stifel Nicolaus Buy $25 → $32
Apr-27-17 09:41PM  Edited Transcript of SPSC earnings conference call or presentation 27-Apr-17 8:30pm GMT Thomson Reuters StreetEvents
06:20PM  SPS Commerce beats Street 1Q forecasts Associated Press
05:14PM  SPS Commerce, Inc. Value Analysis (NASDAQ:SPSC) : April 27, 2017 Capital Cube
04:05PM  SPS Commerce Reports First Quarter 2017 Financial Results GlobeNewswire
10:50AM  Investor Network: SPS Commerce, Inc. to Host Earnings Call Accesswire
Apr-26-17 09:20AM  SPS Commerce, Inc. breached its 50 day moving average in a Bearish Manner : SPSC-US : April 26, 2017 Capital Cube
Apr-13-17 04:05PM  SPS Commerce Announces Date of First Quarter 2017 Financial Results GlobeNewswire
Apr-12-17 09:00AM  Beyond Now: Retail Leaders to Share Insights on Todays Retail Transformation at SPS Commerce In:fluence 2017 GlobeNewswire
Apr-04-17 09:00AM  Retail Leaders Unite to Move Beyond Omnichannel at SPS Commerce In:fluence 2017 GlobeNewswire
09:00AM  Retail Leaders Unite to Move Beyond Omnichannel at SPS Commerce In:fluence 2017
Mar-03-17 01:04PM  SPS COMMERCE INC Financials
Feb-27-17 05:26PM  SPS COMMERCE INC Files SEC form 10-K, Annual Report
Feb-21-17 09:00AM  SPS Commerce to Present at the JMP Securities 2017 Technology Conference GlobeNewswire
Feb-15-17 04:26PM  SPS COMMERCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-09-17 12:17PM  SPS Commerce, Inc. :SPSC-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017 Capital Cube
12:17PM  SPS Commerce, Inc. :SPSC-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017
Feb-08-17 12:42PM  SPS Commerce, Inc. :SPSC-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 -18.86%
07:12AM  SPS Commerce downgraded by Pacific Crest and Canaccord Genuity
Feb-07-17 08:05PM  Edited Transcript of SPSC earnings conference call or presentation 7-Feb-17 9:30pm GMT Thomson Reuters StreetEvents
08:05PM  Edited Transcript of SPSC earnings conference call or presentation 7-Feb-17 9:30pm GMT
06:23PM  SPS Commerce beats Street 4Q forecasts Associated Press
04:08PM  SPS COMMERCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  SPS Commerce Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 SPS Commerce Inc Earnings Release - After Market Close
Feb-01-17 03:03PM  SPS Commerce, Inc. Value Analysis (NASDAQ:SPSC) : February 1, 2017 Capital Cube
03:03PM  SPS Commerce, Inc. Value Analysis (NASDAQ:SPSC) : February 1, 2017
Jan-31-17 10:13AM  SPS Commerce, Inc. breached its 50 day moving average in a Bearish Manner : SPSC-US : January 31, 2017 Capital Cube
10:13AM  SPS Commerce, Inc. breached its 50 day moving average in a Bearish Manner : SPSC-US : January 31, 2017
Jan-26-17 02:20PM  More Retailers Get on Board With 'Drop Shipping' for E-Commerce The Wall Street Journal
02:20PM  More Retailers Get on Board With 'Drop Shipping' for E-Commerce at The Wall Street Journal
Jan-24-17 09:00AM  SPS Commerce In:fluence 2017 Empowers Attendees to Go Beyond with Inspirational Keynote Speakers GlobeNewswire
Jan-17-17 04:05PM  SPS Commerce Announces Date of Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Jan-16-17 08:00AM  Retail Industry Moving Beyond Omnichannel as Consumers Demand Personalized Shopping Experiences Across Channels GlobeNewswire
Jan-10-17 09:10AM  SPS Commerce and Deposco Deliver Orchestrated Retail Solutions to Advance the Digital Supply Chain GlobeNewswire
Jan-03-17 04:05PM  SPS Commerce to Present at the 19th Annual Needham Growth Conference GlobeNewswire
Dec-21-16 06:57AM  Avis Closes France Cars Buyout to Boost Global Presence
Dec-19-16 08:35AM  Xerox's (XRX) Strategic Efforts Bode Well, Risks Remain
Dec-12-16 02:35AM  SPS Commerce, Inc. (SPSC): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-02-16 11:06AM  ETFs with exposure to SPS Commerce, Inc. : December 2, 2016
Dec-01-16 07:16AM  SPS Commerce, Inc. breached its 50 day moving average in a Bullish Manner : SPSC-US : December 1, 2016
Nov-10-16 09:30AM  Zacks.com featured highlights: SPS Commerce, CryoLife, FormFactor, Willdan Group and LegacyTexas Financial Group
Nov-09-16 08:01AM  Focus On 5 Best Profitable Stocks for Desirable Returns
Nov-04-16 09:30AM  Zacks.com featured highlights: Activision Blizzard, Gibraltar Industries, Northrop Grumman, SJW and SPS Commerce
Nov-03-16 10:15AM  Follow Driehaus' Rule & Pick These 5 Momentum Stocks
Oct-28-16 07:17PM  Edited Transcript of SPSC earnings conference call or presentation 27-Oct-16 8:30pm GMT -7.22%
04:05PM  SPS COMMERCE INC Files SEC form 10-Q, Quarterly Report
Oct-27-16 07:05PM  SPS Commerce tops Street 3Q forecasts AP
04:09PM  SPS COMMERCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  SPS Commerce Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 SPS Commerce Inc Earnings Release - After Market Close
Oct-26-16 09:14AM  Business Service Stocks Earnings on Oct 27: EXLS, FCN & More
Oct-25-16 05:05PM  Breakout Watch: RealPage Rallies Into Buy Zone Ahead Of Earnings
Oct-21-16 08:51AM  SPS Commerce, Inc. breached its 50 day moving average in a Bearish Manner : SPSC-US : October 21, 2016
Oct-06-16 04:05PM  SPS Commerce Announces Date of Third Quarter 2016 Financial Results GlobeNewswire
Sep-30-16 04:54PM  Four Top Software Stocks That Are Tough To Top
Sep-22-16 08:35AM  SPS Commerce (SPSC) in Focus: Stock Jumps 6.5% in Session
Sep-21-16 12:30AM  IHS Tears Down the iPhone 7, Mast Therapeutics Crashes On Trial Failure, Plus the Latest Hype On 3 Other Stocks at Insider Monkey +6.53%
Sep-20-16 06:14PM  The Cooper Companies Set to Join the S&P 500; Northwestern and NuVasive to Join S&P MidCap 400; SPS Commerce and Fox Factory to Join S&P SmallCap 600 PR Newswire
Sep-19-16 10:46AM  ETFs with exposure to SPS Commerce, Inc. : September 19, 2016
Sep-16-16 09:29AM  SPS Commerce, Inc. :SPSC-US: Earnings Analysis: Q2, 2016 By the Numbers : September 16, 2016
Aug-03-16 04:05PM  SPS Commerce Announces Schedule of Upcoming Investor Conferences GlobeNewswire
09:24AM  Avis (CAR) Q2 Earnings Miss, Stock Up on Raised 2016 View
Jul-29-16 04:23PM  SPS COMMERCE INC Files SEC form 10-Q, Quarterly Report
Jul-28-16 08:11AM  Edited Transcript of SPSC earnings conference call or presentation 27-Jul-16 8:30pm GMT
07:25AM  SPS Commerce tops Street 2Q forecasts AP
Jul-27-16 04:08PM  SPS COMMERCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  SPS Commerce Reports Second Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q2 2016 SPS Commerce Inc Earnings Release - After Market Close
Jul-06-16 04:05PM  SPS Commerce Announces Date of Second Quarter 2016 Financial Results GlobeNewswire
Jun-30-16 04:06PM  ETFs with exposure to SPS Commerce, Inc. : June 30, 2016
Jun-28-16 02:01PM  SPS Commerce, Inc. :SPSC-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
May-26-16 04:05PM  SPS Commerce Announces Schedule of Upcoming Investor Conferences GlobeNewswire
May-18-16 05:32PM  SPS COMMERCE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-04-16 06:01PM  5 Best States for Tech Jobs (SPSC, AMZN) at Investopedia
Apr-29-16 04:12PM  SPS COMMERCE INC Files SEC form 10-Q, Quarterly Report
Apr-27-16 10:30AM  Leading Retailers and Brands Turn to SPS Commerce Fulfillment to Advance Beyond EDI for the Digital Retail Era GlobeNewswire
Apr-26-16 02:08PM  ETFs with exposure to SPS Commerce, Inc. : April 26, 2016
Apr-25-16 10:57AM  SPS Commerce, Inc. :SPSC-US: Earnings Analysis: Q1, 2016 By the Numbers
Apr-22-16 04:46PM  Edited Transcript of SPSC earnings conference call or presentation 21-Apr-16 8:30pm GMT
Apr-21-16 05:11PM  SPS Commerce beats Street 1Q forecasts
04:08PM  SPS COMMERCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  SPS Commerce Reports First Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q1 2016 SPS Commerce Inc Earnings Release - After Market Close CCBN
Apr-19-16 11:21AM  SPS Commerce, Inc. Value Analysis (NASDAQ:SPSC) : April 19, 2016
Apr-18-16 11:46AM  Cvent Takeout Shines Spotlight on Cloud Software Providers at TheStreet
08:05AM  SPS Commerce, Inc. breached its 50 day moving average in a Bullish Manner : SPSC-US : April 18, 2016
Apr-12-16 09:00AM  Leading Retail Executives to Inform and Inspire Digital Retail Transformation at SPS Commerce In:fluence 2016 GlobeNewswire
Apr-07-16 04:05PM  SPS Commerce Announces Date of First Quarter 2016 Financial Results GlobeNewswire
Mar-29-16 04:36PM  Retail Technology Experts Pave the Way for Industry Transformation at SPS Commerce In:fluence 2016 at noodls
04:05PM  Retail Technology Experts Pave the Way for Industry Transformation at SPS Commerce In:fluence 2016 GlobeNewswire
Mar-24-16 10:51AM  Sierra Sage builds powerful business relationship via SPS In:fluence at noodls
Mar-23-16 12:04PM  SPS Commerce heading to 2016 SUN Conference at noodls
Feb-24-16 05:27PM  SPS COMMERCE INC Files SEC form 10-K, Annual Report
Feb-22-16 04:05PM  SPS Commerce to Present at the JMP Securities Technology Conference GlobeNewswire
Feb-15-16 09:00AM  SPS Commerce In:fluence 2016 Keynote Speakers Set to Inspire the Retail Industry GlobeNewswire
Feb-11-16 03:44PM  SPS Commerce feels the squeeze of a tightening labor market at bizjournals.com
Feb-08-16 10:22AM  SPS Commerce, Inc. Earnings Analysis: 2015 By the Numbers -5.74%
Feb-04-16 04:58PM  SPS Commerce (SPSC) Stock Price Target Cut at JMP Securities at TheStreet -20.25%
Feb-03-16 08:34PM  Edited Transcript of SPSC earnings conference call or presentation 3-Feb-16 9:30pm GMT
05:45PM  SPS Commerce tops Street 4Q forecasts AP
SPS Commerce, Inc. provides cloud-based supply chain management solutions worldwide. It provides solutions through the SPS Commerce platform, a cloud-based product suite that enhances the way suppliers, retailers, distributors, logistics firms, and other trading partners manage and fulfill orders. The company offers Trading Partner Fulfillment solution, which provides fulfillment automation and replaces or augments an organization's existing trading partner electronic communication infrastructure; Trading Partner Analytics solution that comprises data analytics applications to enhance visibility and analysis of customers supply chains; and Trading Partner Assortment solution to manage individual attributes associated with each item a retailer or supplier sells. It also provides Trading Partner Sourcing solution that enables retailers to source providers of new items, suppliers to connect with new retailers, and retailing community to make connections for expanding their business networks and grow; Trading Partner Community Development solution, which offers communications programs that enables retailers, suppliers, and emerging providers of value-added products and services to establish trading partner relationships with new trading partners to expand their businesses; and Other Trading Partner Solutions, such as barcode labeling, planogram services, and scan and pack application that helps trading partners process information to streamline the picking and packaging process. The company sells its solutions primarily through retail sales professionals and supplier sales representatives to small- to mid-sized suppliers in the consumer packaged goods industry, as well as retailers, distributors, third-party logistics providers, and other trading partners. The company was formerly known as St. Paul Software, Inc. and changed its name to SPS Commerce, Inc. in May 2001. SPS Commerce, Inc. was incorporated in 1987 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Black Archie C.CEOMar 01Option Exercise16.6415,000249,600103,380Mar 03 06:05 PM
Black Archie C.CEOMar 01Sale55.8715,000837,99488,380Mar 03 06:05 PM
Frome James J.EVP & Chief Operating OfficerFeb 10Sale58.014,618267,88312,993Feb 14 08:10 PM
Frome James J.EVP & Chief Operating OfficerFeb 06Sale66.972,859191,46617,611Feb 08 05:18 PM
Black Archie C.CEOFeb 02Option Exercise16.645,37189,37373,971Feb 03 05:36 PM
Black Archie C.CEOFeb 02Sale68.135,371365,90368,600Feb 03 05:36 PM
Black Archie C.CEOFeb 01Option Exercise16.649,629160,22778,229Feb 03 05:36 PM
Black Archie C.CEOFeb 01Sale68.059,629655,23068,600Feb 03 05:36 PM
Black Archie C.CEOJan 04Option Exercise16.641,38523,04669,985Jan 05 05:26 PM
Black Archie C.CEOJan 04Sale70.031,38596,99568,600Jan 05 05:26 PM
Black Archie C.CEOJan 03Option Exercise16.6413,615226,55482,215Jan 05 05:26 PM
Black Archie C.CEOJan 03Sale69.2013,615942,11968,600Jan 05 05:26 PM
SORAN PHILIPDirectorNov 16Option Exercise27.552,67273,6147,938Nov 18 05:26 PM
SORAN PHILIPDirectorNov 16Sale66.282,672177,1025,266Nov 18 05:26 PM
Frome James J.EVP & Chief Operating OfficerNov 02Option Exercise25.323,94599,88724,415Nov 03 05:11 PM
Frome James J.EVP & Chief Operating OfficerNov 02Sale62.193,945245,34120,470Nov 03 05:11 PM
Frome James J.EVP & Chief Operating OfficerNov 01Option Exercise25.3212,023304,42232,493Nov 03 05:11 PM
Frome James J.EVP & Chief Operating OfficerNov 01Sale62.2512,023748,47020,470Nov 03 05:11 PM
Black Archie C.CEOSep 02Option Exercise16.641,44824,09570,048Sep 06 05:16 PM
Smerklo Michael ADirectorSep 02Sale67.4058039,092760Sep 06 05:18 PM
Black Archie C.CEOSep 02Sale65.651,44895,06568,600Sep 06 05:16 PM
Black Archie C.CEOSep 01Option Exercise16.648,552142,30577,152Sep 06 05:16 PM
Black Archie C.CEOSep 01Sale65.268,552558,13468,600Sep 06 05:16 PM
LEESTMA MARTIN JDirectorAug 22Sale65.811,50098,7113,093Aug 24 04:25 PM
WEHRWEIN SVENDirectorAug 02Option Exercise8.963,02527,1106,493Aug 04 04:17 PM
WEHRWEIN SVENDirectorAug 02Sale64.993,025196,5944,593Aug 04 04:17 PM
Smerklo Michael ADirectorAug 02Sale65.7458138,1981,340Aug 04 04:15 PM
Black Archie C.CEOAug 01Option Exercise16.6410,000166,40078,600Aug 03 05:24 PM
Black Archie C.CEOAug 01Sale63.3810,000633,76568,600Aug 03 05:24 PM
Black Archie C.CEOJun 01Option Exercise12.0010,000120,00078,600Jun 03 05:53 PM
Black Archie C.CEOJun 01Sale56.0110,000560,05268,600Jun 03 05:53 PM
Black Archie C.CEOMay 02Option Exercise12.0010,000120,00078,600May 04 05:53 PM
Black Archie C.CEOMay 02Sale51.6310,000516,29068,600May 04 05:53 PM
CRME Cardiome Pharma Corp. daily Stock Chart
CRME [NASD]
Cardiome Pharma Corp.
Index- P/E- EPS (ttm)-0.79 Insider Own0.80% Shs Outstand32.40M Perf Week6.39%
Market Cap107.89M Forward P/E- EPS next Y-0.29 Insider Trans0.00% Shs Float31.30M Perf Month8.82%
Income-19.60M PEG- EPS next Q-0.14 Inst Own76.60% Short Float0.33% Perf Quarter14.83%
Sales25.30M P/S4.26 EPS this Y42.20% Inst Trans-0.23% Short Ratio1.48 Perf Half Y16.43%
Book/sh1.07 P/B3.11 EPS next Y46.30% ROA-32.60% Target Price6.68 Perf Year-26.33%
Cash/sh0.83 P/C4.03 EPS next 5Y28.00% ROE-73.80% 52W Range2.35 - 6.36 Perf YTD20.65%
Dividend- P/FCF- EPS past 5Y19.40% ROI-30.20% 52W High-48.43% Beta1.33
Dividend %- Quick Ratio3.40 Sales past 5Y75.80% Gross Margin75.00% 52W Low39.57% ATR0.11
Employees85 Current Ratio3.80 Sales Q/Q48.90% Oper. Margin-63.40% RSI (14)65.05 Volatility4.02% 4.10%
OptionableYes Debt/Eq0.57 EPS Q/Q52.30% Profit Margin-77.70% Rel Volume1.09 Prev Close3.33
ShortableYes LT Debt/Eq0.57 EarningsMar 07 AMC Payout- Avg Volume69.66K Price3.28
Recom1.90 SMA205.30% SMA506.99% SMA2006.65% Volume29,195 Change-1.50%
Dec-22-16Initiated Leerink Partners Outperform
Jun-01-16Initiated H.C. Wainwright Buy $9.50
Jan-08-15Initiated Brean Capital Buy $13
Jan-07-14Initiated R. F. Lafferty Buy $9
Mar-20-12Downgrade RBC Capital Mkts Outperform → Sector Perform $6 → $1.50
Apr-27-11Upgrade RBC Capital Mkts Sector Perform → Outperform $8
Dec-08-10Initiated Wedbush Outperform $8.50
Oct-22-10Reiterated RBC Capital Mkts Sector Perform $10 → $9
Jun-23-10Reiterated UBS Buy $8.80 → $10.75
Aug-12-09Reiterated RBC Capital Mkts Sector Perform $11.50 → $9
Mar-19-09Reiterated Leerink Swann Outperform $8 → $6
Dec-01-08Reiterated Oppenheimer Outperform $18 → $15
Nov-17-08Reiterated Leerink Swann Outperform $15 → $8
Aug-12-08Reiterated RBC Capital Mkts Sector Perform $13.50 → $11.50
Aug-12-08Reiterated Lehman Brothers Equal-Weight $10 → $8
Jul-16-08Downgrade RBC Capital Mkts Outperform → Sector Perform $13.50
Mar-20-08Initiated Wachovia Outperform
Mar-11-08Initiated BMO Capital Markets Market Perform
Oct-09-07Initiated Lehman Brothers Equal-weight
Feb-23-07Initiated Bear Stearns Outperform $17
Apr-27-17 08:00AM  Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference PR Newswire
Apr-10-17 08:45AM  Cardiome Pharma (CRME) Jumps: Stock Adds 6.6% in Session Zacks
Apr-06-17 08:00AM  Cardiome's Partner SteadyMed Announces Successful Completion of Trevyent® Clinical Validation Study PR Newswire
Apr-03-17 08:00AM  Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review PR Newswire
Apr-01-17 01:04PM  CARDIOME PHARMA CORP Financials
Mar-31-17 08:00AM  Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors GlobeNewswire
Mar-20-17 09:04AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
Mar-16-17 09:55AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017 Capital Cube
Mar-14-17 03:02PM  Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS PR Newswire
03:02PM  Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS CNW Group
Mar-07-17 04:20PM  Cardiome reports 4Q loss Associated Press
04:00PM  Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results PR Newswire
04:00PM  Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results CNW Group
Mar-03-17 08:00AM  Cardiome Announces Commercial Launch of Xydalba (dalbavancin) in France PR Newswire
Feb-27-17 08:00AM  Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7 PR Newswire
08:00AM  Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7 CNW Group
Dec-22-16 06:58AM  Coverage initiated on Cardiome Pharma by Leerink Partners
Dec-20-16 08:00AM  Cardiome Announces Commercial Launch of XYDALBA (dalbavancin) in Germany PR Newswire
Dec-13-16 07:04PM  Is CARDIOME PHARMA CORP (CRME) a Good Stock to Buy? at Insider Monkey
Dec-08-16 11:55AM  Cardiome Announces Commercial Launch of Xydalba (dalbavancin) in the UK PR Newswire
Nov-29-16 08:00AM  Cardiome Advances Toward the UK XYDALBA (dalbavancin) Launch PR Newswire
Nov-09-16 11:48AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016
Nov-07-16 08:12AM  Cardiome reports 3Q loss +9.80%
08:00AM  Cardiome Reports Third Quarter 2016 Financial Results PR Newswire
Nov-01-16 08:00AM  Cardiome to Reschedule Release of Third Quarter 2016 Financial Results PR Newswire
Oct-28-16 08:00AM  Cardiome to Hold Third Quarter 2016 Financial Results Conference Call on November 7 PR Newswire
Oct-26-16 09:14AM  New Strong Sell Stocks for October 26th
Oct-14-16 09:15AM  New Strong Sell Stocks for October 14th
08:00AM  Cardiome Announces Initiation of Commercial Operations in Canada, Eh PR Newswire
Aug-16-16 08:00AM  Cardiome Announces Recent Insider Purchases PR Newswire
Aug-11-16 10:44AM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-09-16 04:47PM  Cardiome reports 2Q loss
04:00PM  Cardiome Reports Second Quarter 2016 Financial Results PR Newswire
04:00PM  Cardiome Announces XYDALBA Single Dose Infusion Approval by European Medicines Agency PR Newswire
Aug-08-16 08:00AM  Cardiome Announces the Addition of Two Key Members to its Management Team PR Newswire
Aug-03-16 04:30PM  Cardiome to Hold Second Quarter 2016 Financial Results Conference Call on August 9 PR Newswire
Jul-29-16 09:53AM  Cardiome Closes Public Offering of 11,500,000 Common Shares PR Newswire
Jul-27-16 04:04PM  New York Community Bank Drops in on Wednesdays 52-Week Low Club at 24/7 Wall St.
Jul-26-16 04:08PM  Noodles, Cardiome Lead Tuesdays 52-Week Low Club at 24/7 Wall St. -43.21%
08:38AM  Cardiome Announces Pricing of Public Offering of 10,000,000 Common Shares PR Newswire
Jul-25-16 04:01PM  Cardiome Announces Proposed Public Offering of Common Shares PR Newswire
Jul-18-16 08:00AM  Ionis Pharmaceuticals (IONS) in Focus: Stock Soars 11.3%
Jul-14-16 08:00AM  ESMOCARD® and ESMOCARD LYO® receive pricing approval and reimbursement in Italy PR Newswire
Jun-24-16 08:00AM  Cardiome Pharma Corp. Announces Voting Results PR Newswire
Jun-14-16 08:00AM  Cardiome Announces Term Loan Agreement with CRG-Managed Funds PR Newswire
Jun-04-16 11:25AM  2 Small-Cap Speculative Biohealth Stocks Called to Double or Rise Exponentially at 24/7 Wall St.
May-23-16 01:23PM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
08:25AM  Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher
May-13-16 07:11AM  Cardiome reports 1Q loss
07:00AM  Cardiome Reports First Quarter 2016 Financial Results PR Newswire
May-12-16 08:00AM  Cardiome Announces the Launch of ESMOCARD Solution for Injection in France PR Newswire
May-11-16 08:00AM  Cardiome to Hold First Quarter 2016 Financial Results Conference Call on May 13 PR Newswire
08:00AM  Cardiome Announces Publication of Spanish Emergency Department BRINAVESS Study PR Newswire
May-10-16 09:45AM  Drug Stocks Q1 Earnings Slated on May 11: ACRS, EARS & More Zacks
May-05-16 04:15PM  Cardiome and Allergan Announce XYDALBA (Dalbavancin) Licensing Agreement in International Markets PR Newswire
Apr-28-16 08:00AM  Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference PR Newswire
Apr-25-16 09:16AM  New Strong Sell Stocks for April 25th Zacks -5.23%
Apr-21-16 06:30PM  A Closer Look Into Veritas Pharma Gurufocus
Apr-14-16 08:51AM  New Strong Sell Stocks for April 14th
Mar-31-16 08:00AM  Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients with Recent-Onset Atrial Fibrillation PR Newswire
Mar-29-16 09:07AM  New Strong Sell Stocks for March 29th +6.87%
Mar-24-16 08:47AM  New Strong Sell Stocks for March 24th
Mar-23-16 02:54PM  Fairholme Cuts Stake in Sears Holdings Corp (SHLD), Ubben Sells Even More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Moves at Insider Monkey
Mar-21-16 01:25PM  Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q4, 2015 By the Numbers
10:05AM  New Strong Sell Stocks for March 21st
Mar-10-16 07:27AM  Cardiome reports 4Q loss
07:00AM  Cardiome Reports Fourth Quarter and Full Year 2015 Financial Results PR Newswire
Mar-07-16 05:53PM  Cardiome Announces Filing of Prospectus Supplements PR Newswire
Mar-04-16 03:24PM  Cardiome To Hold Fourth Quarter And Full Year 2015 Financial Results Conference Call On March 10 PR Newswire +6.16%
Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. It offers BRINAVESS (vernakalant (IV)) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; XYDALBA, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and TREVYENT for the treatment of pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.